Thymidylate Synthase Expression, p53, bcl-2, Ki-67 and p27 in Colorectal Cancer: Relationships with Tumor Recurrence and Survival View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2004-12-27

AUTHORS

Gerardo Rosati, Rosistella Chiacchio, Giorgio Reggiardo, Domenico De Sanctis, Luigi Manzione

ABSTRACT

It was the objective to determine in this retrospective study whether thymidylate synthase (TS), p53, bcl-2, Ki-67 and p27 in Dukes' stage B and stage C (AJCC/UICC stage II and III) colorectal adenocarcinoma were predictive of disease-free survival (DFS) and overall survival (OS). Paraffin-embedded specimens from 103 patients with colorectal cancer, treated with surgery between October 1994 and September 1999, were examined for TS expression, p53, bcl-2, Ki-67 and p27 using immunohistochemistry; 51 cases were Dukes' stage B and 52 cases were Dukes' stage C disease. Adjuvant 5-FU-based chemotherapy was given to all patients, while 31 having rectal malignancy also received pelvic radiotherapy. Data were associated with the recurrence rate and survival. With a median follow-up of 5 years, 38 patients (36.8%) developed recurrence and as many patients (36.8%) died. TS was overexpressed in 16 cases (15.6%), p53 nuclear oncoprotein accumulation in >10% of cells occurred more frequently [61 of 103 cases (59.3%)], positive expression of bcl-2 protein in >10% of cells was observed in 41 of 103 cases (39.9%), 57 patients (55.4%) showed immunohistochemical expression of Ki-67 and there were 75 cases (72.9%) with p27 accumulation. The pathological stage was the only independent prognostic factor for DFS (p = 0.042). Sex, as well as age and biological prognostic factors, had no significant impact value on DFS and OS. A multivariate analysis of OS demonstrated that stage C, p53 negative and Ki-67 positive were associated significantly with an unfavorable outcome and a worse median OS (p = 0.035 and t ratio = 2.48). Some biological characteristics such as p53 and Ki-67 status may provide useful prognostic information in addition to the classical clinicopathological parameters. However, further studies are needed to clarify the value of adopting biological prognostic factors into clinical practice. More... »

PAGES

258-263

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1159/000081389

DOI

http://dx.doi.org/10.1159/000081389

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1053456430

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/15627889


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adenocarcinoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemotherapy, Adjuvant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Colorectal Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunohistochemistry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ki-67 Antigen", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Multivariate Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Recurrence, Local", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Staging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proliferating Cell Nuclear Antigen", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proto-Oncogene Proteins c-bcl-2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Suppressor Protein p53", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Medical Oncology Unit and, Histopathology, \u2018S. Carlo\u2019 Hospital of Potenza, Potenza, and, Data Management Unit, Medi Service of Genova, Genova, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Medical Oncology Unit and, Histopathology, \u2018S. Carlo\u2019 Hospital of Potenza, Potenza, and, Data Management Unit, Medi Service of Genova, Genova, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rosati", 
        "givenName": "Gerardo", 
        "id": "sg:person.01362033743.92", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362033743.92"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical Oncology Unit and, Histopathology, \u2018S. Carlo\u2019 Hospital of Potenza, Potenza, and, Data Management Unit, Medi Service of Genova, Genova, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Medical Oncology Unit and, Histopathology, \u2018S. Carlo\u2019 Hospital of Potenza, Potenza, and, Data Management Unit, Medi Service of Genova, Genova, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chiacchio", 
        "givenName": "Rosistella", 
        "id": "sg:person.0606020042.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0606020042.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical Oncology Unit and, Histopathology, \u2018S. Carlo\u2019 Hospital of Potenza, Potenza, and, Data Management Unit, Medi Service of Genova, Genova, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Medical Oncology Unit and, Histopathology, \u2018S. Carlo\u2019 Hospital of Potenza, Potenza, and, Data Management Unit, Medi Service of Genova, Genova, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Reggiardo", 
        "givenName": "Giorgio", 
        "id": "sg:person.01251446443.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251446443.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical Oncology Unit and, Histopathology, \u2018S. Carlo\u2019 Hospital of Potenza, Potenza, and, Data Management Unit, Medi Service of Genova, Genova, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Medical Oncology Unit and, Histopathology, \u2018S. Carlo\u2019 Hospital of Potenza, Potenza, and, Data Management Unit, Medi Service of Genova, Genova, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "De Sanctis", 
        "givenName": "Domenico", 
        "id": "sg:person.01050660100.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050660100.85"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical Oncology Unit and, Histopathology, \u2018S. Carlo\u2019 Hospital of Potenza, Potenza, and, Data Management Unit, Medi Service of Genova, Genova, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Medical Oncology Unit and, Histopathology, \u2018S. Carlo\u2019 Hospital of Potenza, Potenza, and, Data Management Unit, Medi Service of Genova, Genova, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Manzione", 
        "givenName": "Luigi", 
        "id": "sg:person.01260533117.65", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260533117.65"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.bjc.6690091", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025862764", 
          "https://doi.org/10.1038/sj.bjc.6690091"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6690033", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038295854", 
          "https://doi.org/10.1038/sj.bjc.6690033"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2004-12-27", 
    "datePublishedReg": "2004-12-27", 
    "description": "It was the objective to determine in this retrospective study whether thymidylate synthase (TS), p53, bcl-2, Ki-67 and p27 in Dukes' stage B and stage C (AJCC/UICC stage II and III) colorectal adenocarcinoma were predictive of disease-free survival (DFS) and overall survival (OS). Paraffin-embedded specimens from 103 patients with colorectal cancer, treated with surgery between October 1994 and September 1999, were examined for TS expression, p53, bcl-2, Ki-67 and p27 using immunohistochemistry; 51 cases were Dukes' stage B and 52 cases were Dukes' stage C disease. Adjuvant 5-FU-based chemotherapy was given to all patients, while 31 having rectal malignancy also received pelvic radiotherapy. Data were associated with the recurrence rate and survival. With a median follow-up of 5 years, 38 patients (36.8%) developed recurrence and as many patients (36.8%) died. TS was overexpressed in 16 cases (15.6%), p53 nuclear oncoprotein accumulation in >10% of cells occurred more frequently [61 of 103 cases (59.3%)], positive expression of bcl-2 protein in >10% of cells was observed in 41 of 103 cases (39.9%), 57 patients (55.4%) showed immunohistochemical expression of Ki-67 and there were 75 cases (72.9%) with p27 accumulation. The pathological stage was the only independent prognostic factor for DFS (p = 0.042). Sex, as well as age and biological prognostic factors, had no significant impact value on DFS and OS. A multivariate analysis of OS demonstrated that stage C, p53 negative and Ki-67 positive were associated significantly with an unfavorable outcome and a worse median OS (p = 0.035 and t ratio = 2.48). Some biological characteristics such as p53 and Ki-67 status may provide useful prognostic information in addition to the classical clinicopathological parameters. However, further studies are needed to clarify the value of adopting biological prognostic factors into clinical practice.", 
    "genre": "article", 
    "id": "sg:pub.10.1159/000081389", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1091981", 
        "issn": [
          "1010-4283", 
          "1423-0380"
        ], 
        "name": "Tumor Biology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5-6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "25"
      }
    ], 
    "keywords": [
      "disease-free survival", 
      "Dukes' stage B", 
      "stage C disease", 
      "biological prognostic factors", 
      "overall survival", 
      "prognostic factors", 
      "stage B", 
      "colorectal cancer", 
      "Dukes' stage C disease", 
      "only independent prognostic factor", 
      "independent prognostic factor", 
      "useful prognostic information", 
      "thymidylate synthase", 
      "worse median OS", 
      "classical clinicopathological parameters", 
      "Adjuvant 5-FU", 
      "median OS", 
      "Ki-67 status", 
      "pelvic radiotherapy", 
      "retrospective study", 
      "recurrence rate", 
      "tumor recurrence", 
      "rectal malignancies", 
      "pathological stage", 
      "unfavorable outcome", 
      "prognostic information", 
      "colorectal adenocarcinoma", 
      "clinicopathological parameters", 
      "immunohistochemical expression", 
      "synthase expression", 
      "p53 negative", 
      "clinical practice", 
      "patients", 
      "stage C", 
      "multivariate analysis", 
      "TS expression", 
      "Ki-67", 
      "positive expression", 
      "survival", 
      "p27 accumulation", 
      "Further studies", 
      "recurrence", 
      "p27", 
      "cancer", 
      "p53", 
      "Bcl-2", 
      "Bcl-2 protein", 
      "biological characteristics", 
      "expression", 
      "chemotherapy", 
      "surgery", 
      "adenocarcinoma", 
      "cells", 
      "radiotherapy", 
      "malignancy", 
      "cases", 
      "immunohistochemistry", 
      "factors", 
      "disease", 
      "age", 
      "outcomes", 
      "sex", 
      "study", 
      "accumulation", 
      "paraffin", 
      "status", 
      "synthase", 
      "years", 
      "specimens", 
      "negatives", 
      "protein", 
      "rate", 
      "objective", 
      "practice", 
      "stage", 
      "addition", 
      "values", 
      "data", 
      "relationship", 
      "analysis", 
      "characteristics", 
      "information", 
      "parameters", 
      "impact value", 
      "stage C (AJCC/UICC stage II and III) colorectal adenocarcinoma", 
      "C (AJCC/UICC stage II and III) colorectal adenocarcinoma", 
      "C disease", 
      "p53 nuclear oncoprotein accumulation", 
      "nuclear oncoprotein accumulation", 
      "oncoprotein accumulation", 
      "significant impact value"
    ], 
    "name": "Thymidylate Synthase Expression, p53, bcl-2, Ki-67 and p27 in Colorectal Cancer: Relationships with Tumor Recurrence and Survival", 
    "pagination": "258-263", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1053456430"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1159/000081389"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "15627889"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1159/000081389", 
      "https://app.dimensions.ai/details/publication/pub.1053456430"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:16", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_393.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1159/000081389"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1159/000081389'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1159/000081389'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1159/000081389'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1159/000081389'


 

This table displays all metadata directly associated to this object as RDF triples.

269 TRIPLES      22 PREDICATES      139 URIs      129 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1159/000081389 schema:about N05843a3802e748bdb946688b884b486a
2 N0e6825e197ec4f32ad505851f0977465
3 N0e95f1d22a494c26a87077999ee9f15a
4 N164cf1bdd89c4a368bd3434978686d1a
5 N1ce5a5a6c1bb4c0187ef3e69533d6d75
6 N1d6e9ad1a364451da4353cfb6aaa4125
7 N36f91134b74541cbb13d4c61900e6a25
8 N3f990da6a49e4d82963e9ccd4b8a5b65
9 N684e8718242b48c49d1e049ab42be0d2
10 N88c761e7c54d44a1bed564b8b0f6857b
11 N89aba561455949ba923f386e13048d02
12 N8b70f4dbd1874bd0b7c041bcea99531d
13 N93f93557849a461f9ef8d2ed663ad9a8
14 Nbc342a3321044146b9fe1443c582e741
15 Nc18e9db0b2414fc1be02a8f5a571f3d6
16 Ne0fd19b204da452cacdd7c1885aa4d63
17 Ne767211520b641c4989ef62d4ef5aa15
18 Nec447f9f8e9d4c60b575bd0ef347b015
19 Nf5be259b015c4cdf9782b985d58273c4
20 Nf92f9706832c483ca63b16abfad3241c
21 anzsrc-for:11
22 anzsrc-for:1112
23 schema:author Ncb4816ce8f39449cbd97a6a3a75dfd04
24 schema:citation sg:pub.10.1038/sj.bjc.6690033
25 sg:pub.10.1038/sj.bjc.6690091
26 schema:datePublished 2004-12-27
27 schema:datePublishedReg 2004-12-27
28 schema:description It was the objective to determine in this retrospective study whether thymidylate synthase (TS), p53, bcl-2, Ki-67 and p27 in Dukes' stage B and stage C (AJCC/UICC stage II and III) colorectal adenocarcinoma were predictive of disease-free survival (DFS) and overall survival (OS). Paraffin-embedded specimens from 103 patients with colorectal cancer, treated with surgery between October 1994 and September 1999, were examined for TS expression, p53, bcl-2, Ki-67 and p27 using immunohistochemistry; 51 cases were Dukes' stage B and 52 cases were Dukes' stage C disease. Adjuvant 5-FU-based chemotherapy was given to all patients, while 31 having rectal malignancy also received pelvic radiotherapy. Data were associated with the recurrence rate and survival. With a median follow-up of 5 years, 38 patients (36.8%) developed recurrence and as many patients (36.8%) died. TS was overexpressed in 16 cases (15.6%), p53 nuclear oncoprotein accumulation in >10% of cells occurred more frequently [61 of 103 cases (59.3%)], positive expression of bcl-2 protein in >10% of cells was observed in 41 of 103 cases (39.9%), 57 patients (55.4%) showed immunohistochemical expression of Ki-67 and there were 75 cases (72.9%) with p27 accumulation. The pathological stage was the only independent prognostic factor for DFS (p = 0.042). Sex, as well as age and biological prognostic factors, had no significant impact value on DFS and OS. A multivariate analysis of OS demonstrated that stage C, p53 negative and Ki-67 positive were associated significantly with an unfavorable outcome and a worse median OS (p = 0.035 and t ratio = 2.48). Some biological characteristics such as p53 and Ki-67 status may provide useful prognostic information in addition to the classical clinicopathological parameters. However, further studies are needed to clarify the value of adopting biological prognostic factors into clinical practice.
29 schema:genre article
30 schema:inLanguage en
31 schema:isAccessibleForFree false
32 schema:isPartOf N07ff7e91c0bb4d8481fd4e0c980a0901
33 N72630500fee74935b21c7417763f4f57
34 sg:journal.1091981
35 schema:keywords Adjuvant 5-FU
36 Bcl-2
37 Bcl-2 protein
38 C (AJCC/UICC stage II and III) colorectal adenocarcinoma
39 C disease
40 Dukes' stage B
41 Dukes' stage C disease
42 Further studies
43 Ki-67
44 Ki-67 status
45 TS expression
46 accumulation
47 addition
48 adenocarcinoma
49 age
50 analysis
51 biological characteristics
52 biological prognostic factors
53 cancer
54 cases
55 cells
56 characteristics
57 chemotherapy
58 classical clinicopathological parameters
59 clinical practice
60 clinicopathological parameters
61 colorectal adenocarcinoma
62 colorectal cancer
63 data
64 disease
65 disease-free survival
66 expression
67 factors
68 immunohistochemical expression
69 immunohistochemistry
70 impact value
71 independent prognostic factor
72 information
73 malignancy
74 median OS
75 multivariate analysis
76 negatives
77 nuclear oncoprotein accumulation
78 objective
79 oncoprotein accumulation
80 only independent prognostic factor
81 outcomes
82 overall survival
83 p27
84 p27 accumulation
85 p53
86 p53 negative
87 p53 nuclear oncoprotein accumulation
88 paraffin
89 parameters
90 pathological stage
91 patients
92 pelvic radiotherapy
93 positive expression
94 practice
95 prognostic factors
96 prognostic information
97 protein
98 radiotherapy
99 rate
100 rectal malignancies
101 recurrence
102 recurrence rate
103 relationship
104 retrospective study
105 sex
106 significant impact value
107 specimens
108 stage
109 stage B
110 stage C
111 stage C (AJCC/UICC stage II and III) colorectal adenocarcinoma
112 stage C disease
113 status
114 study
115 surgery
116 survival
117 synthase
118 synthase expression
119 thymidylate synthase
120 tumor recurrence
121 unfavorable outcome
122 useful prognostic information
123 values
124 worse median OS
125 years
126 schema:name Thymidylate Synthase Expression, p53, bcl-2, Ki-67 and p27 in Colorectal Cancer: Relationships with Tumor Recurrence and Survival
127 schema:pagination 258-263
128 schema:productId N709ee770449f40308e4bf57ab81b491b
129 Naccc380c288a4709add7d72564d3292b
130 Nbc0a6f1ce6364edda9f901213da6f80f
131 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053456430
132 https://doi.org/10.1159/000081389
133 schema:sdDatePublished 2021-12-01T19:16
134 schema:sdLicense https://scigraph.springernature.com/explorer/license/
135 schema:sdPublisher N25ef0c3e889345a492fb54f0e23553aa
136 schema:url https://doi.org/10.1159/000081389
137 sgo:license sg:explorer/license/
138 sgo:sdDataset articles
139 rdf:type schema:ScholarlyArticle
140 N05843a3802e748bdb946688b884b486a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Ki-67 Antigen
142 rdf:type schema:DefinedTerm
143 N07ff7e91c0bb4d8481fd4e0c980a0901 schema:issueNumber 5-6
144 rdf:type schema:PublicationIssue
145 N0e6825e197ec4f32ad505851f0977465 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Prognosis
147 rdf:type schema:DefinedTerm
148 N0e95f1d22a494c26a87077999ee9f15a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Female
150 rdf:type schema:DefinedTerm
151 N164cf1bdd89c4a368bd3434978686d1a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Colorectal Neoplasms
153 rdf:type schema:DefinedTerm
154 N1ce5a5a6c1bb4c0187ef3e69533d6d75 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Chemotherapy, Adjuvant
156 rdf:type schema:DefinedTerm
157 N1d6e9ad1a364451da4353cfb6aaa4125 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Immunohistochemistry
159 rdf:type schema:DefinedTerm
160 N25ef0c3e889345a492fb54f0e23553aa schema:name Springer Nature - SN SciGraph project
161 rdf:type schema:Organization
162 N36f91134b74541cbb13d4c61900e6a25 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Male
164 rdf:type schema:DefinedTerm
165 N3b79086ea73b4a26b71b78e0ab7df450 rdf:first sg:person.01050660100.85
166 rdf:rest Nf22570370cdc4f25acd2101036945e76
167 N3f990da6a49e4d82963e9ccd4b8a5b65 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Neoplasm Recurrence, Local
169 rdf:type schema:DefinedTerm
170 N6631f8bebf534aa9b278b6a75e6024e7 rdf:first sg:person.01251446443.14
171 rdf:rest N3b79086ea73b4a26b71b78e0ab7df450
172 N684e8718242b48c49d1e049ab42be0d2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Adenocarcinoma
174 rdf:type schema:DefinedTerm
175 N709ee770449f40308e4bf57ab81b491b schema:name doi
176 schema:value 10.1159/000081389
177 rdf:type schema:PropertyValue
178 N72630500fee74935b21c7417763f4f57 schema:volumeNumber 25
179 rdf:type schema:PublicationVolume
180 N88c761e7c54d44a1bed564b8b0f6857b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Proto-Oncogene Proteins c-bcl-2
182 rdf:type schema:DefinedTerm
183 N89aba561455949ba923f386e13048d02 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Tumor Suppressor Protein p53
185 rdf:type schema:DefinedTerm
186 N8b70f4dbd1874bd0b7c041bcea99531d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Retrospective Studies
188 rdf:type schema:DefinedTerm
189 N93f93557849a461f9ef8d2ed663ad9a8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Humans
191 rdf:type schema:DefinedTerm
192 Naa6cb8f2eac1481aa77ec641756c2765 rdf:first sg:person.0606020042.08
193 rdf:rest N6631f8bebf534aa9b278b6a75e6024e7
194 Naccc380c288a4709add7d72564d3292b schema:name pubmed_id
195 schema:value 15627889
196 rdf:type schema:PropertyValue
197 Nbc0a6f1ce6364edda9f901213da6f80f schema:name dimensions_id
198 schema:value pub.1053456430
199 rdf:type schema:PropertyValue
200 Nbc342a3321044146b9fe1443c582e741 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
201 schema:name Middle Aged
202 rdf:type schema:DefinedTerm
203 Nc18e9db0b2414fc1be02a8f5a571f3d6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
204 schema:name Aged
205 rdf:type schema:DefinedTerm
206 Ncb4816ce8f39449cbd97a6a3a75dfd04 rdf:first sg:person.01362033743.92
207 rdf:rest Naa6cb8f2eac1481aa77ec641756c2765
208 Ne0fd19b204da452cacdd7c1885aa4d63 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
209 schema:name Disease-Free Survival
210 rdf:type schema:DefinedTerm
211 Ne767211520b641c4989ef62d4ef5aa15 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
212 schema:name Neoplasm Staging
213 rdf:type schema:DefinedTerm
214 Nec447f9f8e9d4c60b575bd0ef347b015 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
215 schema:name Biomarkers, Tumor
216 rdf:type schema:DefinedTerm
217 Nf22570370cdc4f25acd2101036945e76 rdf:first sg:person.01260533117.65
218 rdf:rest rdf:nil
219 Nf5be259b015c4cdf9782b985d58273c4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
220 schema:name Multivariate Analysis
221 rdf:type schema:DefinedTerm
222 Nf92f9706832c483ca63b16abfad3241c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
223 schema:name Proliferating Cell Nuclear Antigen
224 rdf:type schema:DefinedTerm
225 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
226 schema:name Medical and Health Sciences
227 rdf:type schema:DefinedTerm
228 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
229 schema:name Oncology and Carcinogenesis
230 rdf:type schema:DefinedTerm
231 sg:journal.1091981 schema:issn 1010-4283
232 1423-0380
233 schema:name Tumor Biology
234 schema:publisher Springer Nature
235 rdf:type schema:Periodical
236 sg:person.01050660100.85 schema:affiliation grid-institutes:None
237 schema:familyName De Sanctis
238 schema:givenName Domenico
239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050660100.85
240 rdf:type schema:Person
241 sg:person.01251446443.14 schema:affiliation grid-institutes:None
242 schema:familyName Reggiardo
243 schema:givenName Giorgio
244 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251446443.14
245 rdf:type schema:Person
246 sg:person.01260533117.65 schema:affiliation grid-institutes:None
247 schema:familyName Manzione
248 schema:givenName Luigi
249 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260533117.65
250 rdf:type schema:Person
251 sg:person.01362033743.92 schema:affiliation grid-institutes:None
252 schema:familyName Rosati
253 schema:givenName Gerardo
254 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362033743.92
255 rdf:type schema:Person
256 sg:person.0606020042.08 schema:affiliation grid-institutes:None
257 schema:familyName Chiacchio
258 schema:givenName Rosistella
259 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0606020042.08
260 rdf:type schema:Person
261 sg:pub.10.1038/sj.bjc.6690033 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038295854
262 https://doi.org/10.1038/sj.bjc.6690033
263 rdf:type schema:CreativeWork
264 sg:pub.10.1038/sj.bjc.6690091 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025862764
265 https://doi.org/10.1038/sj.bjc.6690091
266 rdf:type schema:CreativeWork
267 grid-institutes:None schema:alternateName Medical Oncology Unit and, Histopathology, ‘S. Carlo’ Hospital of Potenza, Potenza, and, Data Management Unit, Medi Service of Genova, Genova, Italy
268 schema:name Medical Oncology Unit and, Histopathology, ‘S. Carlo’ Hospital of Potenza, Potenza, and, Data Management Unit, Medi Service of Genova, Genova, Italy
269 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...